Back to results
US 2014/0234870 A1Published application
NIK Inhibitors cell-based screening assay
AssigneeMerck Patent GmbH
InventorsRob Hooft Van Huijsduijnen, Sheraz Gul
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cell-based assay for the screening and the identification of inhibitors of NIK protein. The method according to the present invention allows the identification of compounds that inhibit NIK activity related to the phosphorylation of IKK1. The assay combines the use of transfected Human Embryonic Kidney (HEK) cells with a non-radioactive, homogeneous proximity assay using an “acceptor” bead and a “donor” bead.
Claims7
A method for identifying a compound that inhibits NIK activity, comprising:
- (a) providing HEK cells containing a DNA encoding for NIK and a DNA encoding for IKK1-KD (transfected HEK cells) in a culture medium;
- (b) incubating said transfected HEK cells with and without a candidate molecule to be tested at a temperature of 37° C.+/−2° C. in the presence of 5% CO2 for 24 hours;
- (c) removing the culture medium;
- (d) lysing the cells;
- (e) adding to the cell lysate an acceptor complex followed by a donor complex;
- (f) exciting the cell lysate with a laser illumination and
- (g) measuring the signal arising upon laser excitation of cell lysate using a bead-based luminescent proximity detection system,
- wherein a reduction or the absence of the signal obtained from a cell lysate deriving from transfected HEK cells cultured in the presence of a test compound is indicative of the inhibition of NIK-mediated phosphorylation of IKK1-KD, and wherein the acceptor complex comprises a molecule-coated bead and a binding partner which binds to the IKK1-KD protein and the donor complex comprises a molecule-coated bead and a binding partner which binds to the IKK1-KD protein.
5 more elements
Dependencies are inferred from the claim text.